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ABSTRACT A novel, very-low-frequency electron paramagnetic resonance (EPR) technique is used to image the distribution
of several nitroxides with distinct pharmacologic compartment affinities in the abdomens of living mice. Image acquisition is
sufficiently rapid to allow a time sequence of the distribution for each compound. The spectra and concentrations of these
nitroxides are imaged with the use of spectral-spatial imaging to distinguish a single spatial dimension. Liver and bladder of
the mouse anatomy are distinguished by this technique. After an intraperitoneal injection of the spin-label probes, a shift in
the distribution of the compounds from the upper abdomen (primarily liver) to the lower abdomen (primarily bladder) is
observed. The time dependence of the shift in regional distribution depends on the structural properties of the side chain
attached to the spin label. These results indicate that this application of in vivo electron paramagnetic resonance imaging will
provide a new method of magnetic resonance imaging for determination of pharmacodynamics in the body of an intact
animal.
INTRODUCTION
One of the major challenges in pharmacologic studies is the
determination of the distribution and metabolism of a drug
in an intact animal. To this end radioisotopes are commonly
used tools, yielding quantitative measures of the organ
distribution of a drug (Antar, 1990; Kung, 1990; Stocklin,
1992). Noninvasive imaging permits the time sequence
monitoring of the distribution of a drug (Antar, 1990; Kung,
1990; Reba, 1993; Stocklin, 1992). However, radio nuclear
images may suffer from limited spatial resolution, making it
difficult to apply to laboratory animal models such as mice.
In addition, radio-labeled compounds have short shelf lives
and require specialized production instrumentation (Reba,
1993), both of which increase experimental costs. They may
also be limited by the stability of the drug-radio nuclide
bond with consequent nonspecific tissue uptake of activity
(Stocklin, 1992). Tracers requiring metal chelates may suf-
ficiently alter the molecular weight, the conformation, the
shape, or the pharmacologic properties of the drug to render
the study of low relevance (Stocklin, 1992). Finally, there
are concerns about patient exposure to the radioactive tracer
(Loevinger and Berman, 1976, 1968).
Paramagnetic species can be detected directly by electron
paramagnetic resonance (EPR) imaging (Berliner and Fuji,
1985; Herrling et al., 1982; Lauterbur et al., 1984; Mal-
tempo, 1986) rather by inference of their presence by their
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influence on the relaxation of water hydrogen nuclei, as
must be done in magnetic resonance imaging. The devel-
opment of imaging EPR spectroscopy (Bacic et al., 1988;
Fuchs et al., 1992; Kuppusamy et al., 1994; Maltempo et al.,
1987) at very low frequency (Alecci et al., 1994; Halpern et
al., 1989), under which conditions stable free radicals can be
detected and localized in vivo, permits determination of
drug distribution and metabolism in whole animals. By
using field gradients, one can localize the source of the
resonant signal in small animals such as mice, and images of
the spatial distribution of a paramagnetic species can be
acquired rapidly enough for its time-dependent distribution
to be determined (Alecci et al., 1994). Here we apply this
methodology to determine the time-dependent organ distri-
bution of nitroxides with distinct pharmacologic compart-
ment affinity in the abdomens of C3H mice.
Although results of preliminary studies were reported
earlier (Boisvert et al., 1993; Halpern et al., paper read at
XVII International EPR Symposium, 1994), here we present
results that demonstrate with improved evaluation of the
statistical significance that the time course of the organ
distribution of spin labels in a mouse can be followed by
very-low-frequency EPR imaging. The mouse's major or-
gans are distinguishable along its spinal axis, as shown in
Fig. 1. The use of a single spatial dimension allows rapid
image acquisition. A time sequence of images allows mea-
surement of the time-dependent changes in the net accumu-
lation and release of the spin-labeled compounds along the
spatial dimension corresponding to the locations of the liver
and the bladder after an intraperitoneal injection. Reproduc-
ible changes in the tissue compartmentation of spin-label
compounds are obtained with differences corresponding to
the lipophilic character of the side chain at the 3-position of
the oxypyrrolidinyl and oxypyrrolinyl rings.
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FIGURE 1 Anatomy of the mouse presented diagrammatically. The liver
and the bladder are indicated. Placed next to the diagram is a supine
radiograph of the mouse. The gridded dots are centimeter measuring
marks. The dots not on the grid were used for animal setup and were 12
mm caudad to the scapulae for each mouse. These were used for individual
mouse setup.
The results of these studies indicate that with very-low-
frequency EPR the time course of the organ distribution of
spin labels can be followed. Because the technique is con-
veniently applied and relatively inexpensive, the results
presented indicate that the method could be developed as a
noninvasive technique for the study of the pharmacodynam-
ics of the organ distribution of drugs and of their metabo-
lism.
METHODS
The structural formulas of the spin-label compounds used are shown in Fig.
2. The spin labels 3-trimethylaminomethyl-2,2,5,5-tetramethyl-1-oxypyr-
rolidine iodide (I), 3-carboxy-2,2,5,5-tetramethyl-1-oxypyrroline (II),
3-hydroxymethyl-2,2,5,5-tetramethyl-1-oxypyrrolidine (Ill) and 3-car-
bamoyl-2,2,5,5-tetramethyl-1-oxypyrroline (IV) were synthesized accord-
ing to methods published by others (Rosantzev (1970), IV; Pou et al.
(1995), I; and Hideg et al. (1980), II and Ill). For phantom measurements,
spin label IV was used as the spin probe at a concentration of 200 JIM in
distilled water. For animal measurements the spin-labeled chemicals were
dissolved in distilled water to a concentration of 30 mM (Baker, Phillips-
burg, NJ) and injected as a 0.7 ml intraperitoneal (IP) bolus.
For in vivo imaging studies C3H/sed mice, 10 to 25 weeks old, were
anesthetized with ketamine (45 mg/kg) and diazepam (20 mg/kg) admin-
istered IP, after which the mice were placed prone in a hemicylindrical
acrylic restraint jig. The procedure was painless, but the anesthesia mini-
mized animal motion. The mice were restrained with Elastoplast under
gentle tension. Animals were treated in compliance with Federal regula-
III IV
FIGURE 2 Chemical bonding structures of the four spin-label com-
pounds used for imaging: 3-trimethylaminomethyl-2,2,5,5-tetramethyl-l-
oxypyrrolidine iodide (1), 3-carboxy-2,2,5,5-tetramethyl-l-oxypyrroline
(11), 3-hydroxymethyl-2,2,5,5-tetramethyl-l-oxypyrrolidine (1ff), and
3-carbamoyl-2,2,5,5-tetramethyl-1-oxypyrroline (IV).
tions according to Public Health Service Policy A3532-01 as indicated in
University of Chicago Institutional Animal Care and Use Protocol 52011.
The scapulae of each mouse were palpated, and the caudad tips were
marked with a nonparamagnetic marker. The position of the restraint jig
with the mouse inside was adjusted to place these marks 12 mm outside the
cephalad edge of a resonator 3.2 cm in length. This positioned the dia-
phragmatic domes at the edge of the resonator. X-ray studies of eight mice
of weight 20-25 g positioned in this fashion were taken to measure the
reproducibility of their positions relative to the diaphragmatic domes and
the anterior superior iliac spines.
The rectal temperature was measured before and after measurement
with a Physitemp thermocouple thermometer. Temperature was maintained
at 36.5°C to within 1°C with radiant heating from a gooseneck lamp. The
0.7 ml of a 30 mM spin probe solution was injected IP 10 min after
administration of anesthesia. No toxic reaction was observed. The restraint
jig was suspended independently from the resonator to ensure mechanical
decoupling. Imaging began 3-5 min after administration of the spin label.
Spectra and spectral projections for imaging were obtained with a
low-frequency EPR spectrometer operating at 250 MHz (Halpem et al.,
1989). At this frequency, the skin depth (37% sensitivity) is approximately
7 cm of tissue (Halpern et al., 1989; Roschmann, 1987). This frequency is
far lower than that necessary for measurement deep in the tissues of a
mouse. However, the use of very low frequency minimizes phase-distor-
tion artifacts. The spectrometer consists of a lumped circuit parallel induc-
tance and capacitance resonator, in which the single turn inductance is the
sample holder. The capacitive coupling is adjustable electronically. This
feature allows animal motion and microphonically induced variations in
the coupling to be corrected for variations of frequencies up to several
hundred hertz. The characteristics of the resonator are such that the radio
frequency magnetic field (B1) at an incident radiofrequency power of 100
mW and at a loaded Q (quality factor) of 65 produced by the animal sample
is -0.15 G (Halpern et al., 1989). The modulation frequency was 5.12
kHz. Modulation field amplitude was 0.4 G. Data acquisition was accom-
plished under the control of a microcomputer. Spectral projections were
obtained with 32 points per scan, 10 scans per projection. The time
COOH
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constant and point acquisition time were 0.1 s, giving a projection acqui-
sition time of just over 0.5 min. No weighting was given to high gradient
scans to compensate for the lower signal-to-noise ratio.
Two-dimensional spectral-spatial images (Hayner and Jenkins,
1984; Maltempo et al., 1987, 1988) (one spectral dimension, one spatial
dimension along the spinal axis of the mouse abdomen) were obtained
under continuous-wave conditions. The spectral window was limited to
the central feature of the EPR spectrum of these 14N-containing nitroxyl
spin labels. Samples were subjected to sequences of fixed gradients,
referred to as projections, during spectral acquisition. We generated 16
projections in 17 min by splaying the main field coils to give a
maximum (single) gradient of 2.4 G/cm, similar to that previously
described (Halpern et al., 1989). Each gradient intermixes field strength
and position variables in the same way in which a planar rotation
intermixes Cartesian coordinates in two dimensions for computed to-
mography. Images are then reconstructed by means of backprojection
reconstruction. The algorithm of Hayner (Hayner and Jenkins, 1984) for
incomplete angular coverage was employed. The code for this has been
kindly provided by S. Eaton and G. Eaton (Maltempo et al., 1988) and
was modified by us for our use. This algorithm allows the treatment of
projections that are "missing" because of gradient and scan window
limitations. These studies used a pseudo-object in spectral-spatial space
with a length of 6 cm, a field interval of 5 G, and a Hamming filter
constant of 0.5. This allows the sensitive region of the resonator (length
3.2 cm) to be encompassed fully by the image boundaries. These
settings are such that a single "missing" projection at either extreme is
used in the extrapolation procedure to fill the spectral-spatial space
uniformly.
To understand the spatial resolution provided by the available gradients
for spin labels with - I-G linewidth, we imaged the phantom shown in Fig.
3. The phantom was divided into three axially disposed compartments with
center-to-center distances of 10 mm. The end disks were filled with a 200
,uM solution of spin label IV. The center disk remained empty. The
phantom was imaged as described above for the mice.
RESULTS
Fig. 3 shows the spectral-spatial image obtained with
spin label IV as well as a diagram of the phantom. The
1-G linewidth of IV is virtually identical to that of the
other compounds injected into the mice, providing a
measure of the resolution of this technique under the
gradient and EPR spectral linewidths used. Note that the
smaller peak corresponds to the smaller compartment of
the phantom. The end of the resonator at which the small
compartment was located was the cephalad end of the
resonator for animal measurements. With the compounds
and gradients used, the resolution was 1 cm. With nar-
rower spectral lines, longer acquisition times, or higher
gradients, the resolution can be further extended.
Resolution of 1 cm, however, is sufficient to resolve
the liver and the bladder of the mouse, whose x-ray image
is shown in Fig. 4 next to a spectral-spatial image of its
abdomen. To the left of the spectral-spatial image is a
plot of the spectral maximum as a function of position.
This spatial profile shows two distinct peaks for which
the center positions differ by the same distance as do the
centers of the liver and the bladder. By using the spectral
maximum instead of the projected spectral intensity, we
avoid modest star artifacts from the backprojection re-
construction.
Analysis of the x-ray studies of the mouse diaphrag-
matic domes and anterior superior iliac spines indicated a
standard deviation of 2.5 mm in the positions of these
structures relative to the edges of the resonator. This was
significantly less than the resolution of the images pre-
sented here. For each spin label, sequences of spatial
images were obtained from the spectral-spatial images.
Each image was obtained in 17 min and thereby repre-
sents an average over the changing substrate spatial dis-
tribution over that time interval. We refer to the time at
which the images were obtained as the time midway
between start and finish of the image acquisition, or mean
time of acquisition.
Although this is not evident from the displays, which
are normalized to the maximum value, there is a steady
reduction of the magnitude of the overall signal. Of the
compounds studied, the nonspecific tissue diminution-
bioreduction-of spin label I was by far the slowest. To
shift the focus of this study from overall diminution of
signal with time owing to bioreduction of the nitroxyl
group to spatially and anatomically salient features, we
plot the spatial distributions with the same maximum
value.
Fig. 5 shows the time sequence of spectral-spatial
images obtained from four experiments with spin label II.
FIGURE 3 Spectral-spatial image of a phantom with
compartmentalized spin label IV. The central nitrogen
manifold of the nonderivative spectrum of IV with
unresolved hydrogen hyperfine was included in the
two-dimensional spectral-spatial image (one spatial di-
mension, one spectral dimension) of a phantom consist-
ing of three compartments. The spatial direction imaged
is along the axis of the cylinder. The outer compart-
ments were filled with 200 ,uM spin-label IV in distilled
water, and the middle compartment was left empty. The
small compartment shown farthest into the page occu-
pied the position in the resonator closest to the mouse
head, the cephalad position. This is the location of the
liver. The larger compartment occupied the anatomic
location of the bladder.
Head
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FIGURE 4 Spectral spatial image of a mouse infused with spin-label II. The mouse is oriented with its head into the page. Again, the image is restricted
to the central nitrogen manifold of the nonderivative spectrum of spin label II. The image was obtained in 17 min, a mean of 89 min after IP infusion of
the spin-labeled compound. Distinct peaks can be seen in the region of the liver and bladder.
The figure shows a shaded region about the line repre-
senting the mean + SE, inclusive of the 2.5-mm posi-
tioning uncertainty. The images from different mice in-
jected with the same compound show good consistency.
Fig. 6 depicts the time-dependent changes in the distri-
bution of spin labels I-IV superimposed to accentuate the
distinctive anatomic time-distribution differences of each
compound.
A number of consistencies emerge from the images. The
initial spatial distribution peaks centrally. This is consistent
with the IP distribution of the spin-labeled compound just
after infusion. The next several spatial distributions show
accumulation of the spin-labeled compound toward the
cephalad side of the resonator in the region of the liver.
Again this is to be expected from a compound that is
absorbed through the mesenteric and omental vessels,
which, in turn, feed the portal circulation. Finally, the latter
spatial distributions show an accumulation of signal in the
more caudad aspect of the abdomen consistent with the
location of the bladder. The rate of accumulation of bladder
distribution is the same for various mice injected with the
same compound but varies among compounds.
For compounds I and II there is an early liver component
of the distribution, seen even in the first image in the case
of compound I. The liver component persists for approxi-
mately 100 min, as shown in Fig. 6. Gradually a component
develops in the bladder region. The quaternary amine I was
much longer lived than the carboxylic acid II.
With the methyl alcohol derivative III, the liver compo-
nent of the signal diminishes rapidly relative to the bladder
component. It never emerges as a distinct entity, although it
is suggested in cephalad broadening of the second image
relative to the first. There is a rapid development of a
bladder region peak, which persists as the liver region signal
diminishes. Spin label IV has an intermediate behavior
between I-II and III.
DISCUSSION
We present here a novel application of EPR spectroscopy to
image the pharmacodynamics of simple spin-labeled com-
pounds in mice. Use is made of the technique at very low
frequencies, probably lower than is necessary for clear
signal from such small animals. Moreover, the small size of
the mouse as a sample makes these measurements more
difficult than for a larger animal. As such it provides a proof
of principle for use, without change in frequency, in larger
animal subjects.
The image used here is simplified because it is one
dimensional and is collected with low field gradients. Alecci
and co-workers have used two-dimensional imaging in the
rat to provide imaging pharmacodynamics of a single com-
pound, a carboxylic acid, in the rat (Alecci et al., 1994).
Their images were of higher resolution than those presented
here. However, for analysis, they also take advantage of the
one-dimensional distribution of rodent organ systems to
derive nitroxide distributions similar to those presented
here. The generalization to a three-dimensional system is
straightforward. The implementation of such a system is
under way in our laboratory. It has been pursued at higher
frequencies by Kuppusamy and co-workers (Kuppusamy et
al., 1994) for images derived from a cardiac organ prepa-
ration. The spatial resolution of the system can be improved
by an order of magnitude with higher gradients. Another
half-order-of-magnitude improvement could be gained with
deuterated spin-labeled analogs, the spectra of which ex-
hibit fourfold narrower spectral lines than the lines of the
spin labels used here (Halpern et al., 1993). Further narrow-
ing of the spectral line has been reported for solid-state,
exchange-narrowed paramagnetic probes (Liu et al., 1993).
Although these means of resolution enhancement are prob-
ably optimal in a three-dimensional system, the simple
one-dimensional image form presented here provides a
means for useful and reasonably rapid data acquisition.
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FIGURE 5 Spatial distribution obtained from
the spectral spatial images by plotting the spectral
peak value as a function of position. These distri-
butions are obtained sequentially from spin label
II at the mean time after IP infusion indicated in
each of the six panels. The image obtained in the
first distribution peaks in the middle of the ani-
mal's abdomen. The next image shows the devel-
opment of a distribution peak in the region of the
liver. The distinct peak in this region remains in
the successive images, whereas a peak in the re-
gion of the bladder builds with time, indicative of
spin probe excretion. The shaded region about a
line represents the mean ± SE derived from mea-
surements in four different animals.
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In the results presented in Figs. 5 and 6, the images are
presented normalized to the largest peak. On an absorption
maximum, the absolute values of the spatial peaks typically
diminish jointly by a factor of 4-8 over the time course
presented. This is likely due to nonspecific tissue bioreduc-
tion of the free-radical nitroxyl group. The physiology and
anatomy of the distribution of the spin-labeled compounds
on IP injection argues against the diminution in peak height
being due to bioreduction only. Solutions injected IP are
absorbed by the peritoneum and the omentum, the vessels of
which converge on the portal circulation feeding into the
liver, which, in turn, feeds the general circulation. Blood
from the general circulatory system is rapidly filtered in the
kidney and excreted into the bladder. What is consistently
seen in these images as noted above is the proper sequence
of peak development, as one would expect from this ana-
tomic model of distribution. The use of the normalized
images (each image plotted at the same height despite the
overall reduction in the number of contributing spins),
therefore, eliminates or reduces the contribution of the over-
all bioreduction effect, allowing the technique to expose
distributional or anatomic delivery patterns.
The salient result of this study is the simultaneous mon-
itoring of the distribution of the spin label in the livers and
the bladders of mice and the monitoring of their relative
accumulations. We observe that the liver appears to elimi-
nate the alcohol spin label III, through either excretion or
reduction, far more rapidly than it does the carboxylate or
the tertiary amine. All species appear to have a bladder
accumulation, as expected for these small molecules, which
are excreted in the glomerular filtrate. Whereas bioreduction
undoubtedly occurs in the bladder as the result of ascorbate
in the urine, the reduction of the height of the spatial peak
from the bladder is, in all compounds, slower than that in
the liver.
The spin labeling of drugs and the imaging of their organ
compartmentalization is, perhaps, the most intriguing possibil-
ity offered by this technique. The spin labels used are co-
valently bound to their simple substrates, making the signal
that is specific to these compounds injected. Not only do
nitroxyl spin labels exhibit long half-lives in solution at neutral
pH but the compounds when administered to mice over long
periods of time appear to be nontoxic. Moreover, animal im-
aging can be accomplished in relatively short periods of time
with a moderate technical upgrade, resulting in a resolution
that is far better than those presented here. In summary, we
believe this to be an initial example of a very useful technique
to evaluate a crucial aspect of drug efficacy.
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